Clinical trial

Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects

NCT05176210

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-12-22

PhasePHASE1

Study timeline

Study start (actual)2023-12-22Date precision: day

Registry last updated2026-07-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type II Diabetesunresolved

Interventions

PS1DRUG

PlaceboDRUG

Sponsors & collaborators

Pharmasaga Co. Ltd.lead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05176210 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.